Page last updated: 2024-12-08
hydrel
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
Hydrel: mp 91-93 degrees C; white crystalline substance soluble in H2O, MeOH, EtOH [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 156822 |
MeSH ID | M0085461 |
Synonyms (13)
Synonym |
---|
gidrel |
hydrel |
bis(2-chloroethylphosphonate)hydrazinium |
2-chloroethylphosphonic acid dihydrazine |
gydrel |
t7oh669x5s , |
67255-31-6 |
unii-t7oh669x5s |
74968-27-7 |
phosphonic acid, 2-chloroethyl-,hydrazine salt - |
(2-chloroethyl)phosphonic acid--hydrazine (2/1) |
DTXSID30996467 |
2-chloroethylphosphonic acid;hydrazine |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (4)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 53.56
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (53.56) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |